Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014

Vaccine

Volumn 33, Issue 29, 2015, Pages 3276-3280

  Jiménez Jorge, Silvia ^a,b   Pozo, Francisco ^c   Larrauri, Amparo ^a,b   de Mateo, Salvador ^a,b   Delgado Sanz, Concepción ^a,b   Casas, Inmaculada ^c   García Cenoz, Manuel ^b,d   Castilla, Jesús ^b,d   Rodríguez, Carolina ^e   Vega, Tomás ^e   CarmenQuinones ^f   Martínez, Eva ^f   Vanrell, Juana M ^g   Giménez, Jaume ^g   Castrillejo, Daniel ^h   Altzíbar, Jone M ^b,h   González Carril, Fernando ⁱ   Ramos, Julián M ^j   Serrano, María C ^j   Martínez, Ana ^k,l   Torner, Nuria ^k,l   Pérez, Esteban ^b   Gallardo, Virtudes ^m   more..

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Instituto deSalud Pública de Navarra   (Spain)

^e Prevención Y Educación de la Salud   (Spain)

^f Servicio de Epidemiologia y Prevencion Sanitaria   (Spain)

^g Servicio de Epidemiologia   (Spain)

^h Hospital Comarcal de Melilla   (Spain)

ⁱ Dirección deSalud Pública de Gipuzkoa   (Spain)

^j Servicio de Vigilancia Epidemiológica y Vacunas   (Spain)

^k Unidad Medicalizada de Emergencia   (Spain)

^l Servicio deVigilancia Epidemiológica   (Spain)

^m Secretaria General de SaludPublica y Participacion Consejería de Salud de Andalucía   (Spain)

more..

Author keywords

Case control studies; Influenza; Interim analysis; Sentinel networks; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; HUMAN; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; OBSERVATIONAL STUDY; POPULATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPAIN; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; IMMUNOLOGY; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROCEDURES; SENTINEL SURVEILLANCE; TREATMENT OUTCOME; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SENTINEL SURVEILLANCE; SPAIN; TREATMENT OUTCOME; VACCINATION; YOUNG ADULT;

EID: 84931565596     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.03.051     Document Type: Article

References (20)

1. WHO Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec 2014, 89(10):93-104.
2. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of seasonal influenza vaccine. Vaccine 2013, (30):3104-3109. Available from 〈http://www.sciencedirect.com/science/article/pii/S0264410X13004659〉.
3. Sullivan S.G., Feng S., Cowling B.J. Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review. Expert Rev Vaccines 2014, 13(12):1571-1591.
4. Valenciano M., Ciancio B. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill 2012, 17(39). Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V17N39/art20281.pdf〉.
5. Jimenez-Jorge S., Pozo F., de M.S., Delgado-Sanz C., Casas I., Garcia-Cenoz M., et al. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill 2014, 19(9). Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V19N09/art20727.pdf〉.
6. Savulescu C., Jimenez-Jorge S., de Mateo S., Ledesma J., Pozo F., Casas I., et al. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Euro Surveill 2011, 16(11):1-6. Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V16N11/art19820.pdf〉.
7. Jimenez-Jorge S., de M.S., Pozo F., Casas I., Garcia C.M., Castilla J., et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill 2012, 17(12):1-6. Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V17N12/art20129.pdf〉.
8. Sullivan S.G., Kelly H. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. Euro Surveill 2013, 18(41):20605. Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V18N41/art20605.pdf〉.
9. Belongia E.A., Kieke B.A., Donahue J.G., Coleman L.A., Irving S.A., Meece J.K., et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011, 29(38):6558-6563. Available from 〈http://www.sciencedirect.com/science/article/pii/S0264410X11010231〉.
10. Savulescu C., Valenciano M., de Mateo S., Larrauri A. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine 2010, 28(16):2903-2907. the cycEVA Study Team.
11. Savulescu C., Jimenez-Jorge S., De Mateo S., Pozo F., Casas I., Perez-Brena P., et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case controls studies, Spain, season 2009-2010. BMC Public Health 2011, 11:899-907.
12. Jimenez-Jorge S., Savulescu C., Pozo F., de M.S., Casas I., Ledesma J., et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012, 30:3595-3602.
13. Jimenez-Jorge S., de M.S., Delgado-Sanz C., Pozo F., Casas I., Garcia-Cenoz M., et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. BMC Infect Dis 2013, 13(1):441. Available from 〈http://www.biomedcentral.com/content/pdf/1471-2334-13-441.pdf〉.
14. Jimenez-Jorge S., De Mateo S., Delgado-Sanz C., Pozo F., Casas I., Pérez U., et al. Estimating the 2012/13 influenza vaccine effectiveness using the cycEVA study, the Spanish component of the multicentre I-MOVE study 2013, ESCAIDE 2013 conference.
15. Kissling E., Valenciano M. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill 2012, 17(15):1-7. Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V17N15/art20146.pdf〉.
16. Kissling E., Valenciano M., Larrauri A., Oroszi B., Cohen J., Nunes B., et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013, 18(5). Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V18N05/art20390.pdf〉.
17. Pebody R., Andrews N., McMenamin J., Durnall H., Ellis J., Thompson C., et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013, 18(5). Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V18N05/art20389.pdf〉.
18. Castilla J., Martinez-Baz I., Martinez-Artola V., Reina G., Pozo F., Garcia C.M., et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013, 18(5). Available from 〈http://www.eurosurveillance.org/images/dynamic/EE/V18N05/art20388.pdf〉.
19. European Centre for Disease Control and Prevention (ECDC). ECDC Reviews: WHO recommendation on influenza virus vaccines for the Northern Hemisphere 2013-2014 season. Available from . http://www.ecdc.europa.eu/en/activities/sciadvice/_layouts/forms/Review_DispForm.aspx?ID=737%26&List=a3216f4c-f040-4f51-9f77-a96046dbfd72.
20. Skowronski D.M., Janjua N.Z., Sabaiduc S., De S.G., Winter A.L., Gubbay J.B., et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-12 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis 2014, 210(1):126-137. 10.1093/infdis/jiu048.